|
|
|
Insider
Information: |
Bird Jeffrey W |
Relationship: |
Director, 10% Owner |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
8,735,679 |
|
Indirect Shares
|
2,993,315 |
|
|
Direct
Value |
$146,464,983 |
|
|
Indirect Value
|
$15,395,124 |
|
|
Total
Shares |
11,728,994 |
|
|
Total
Value |
$161,860,107 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
498.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2003-09-26 |
0 |
2017-06-01 |
1,128,034 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director, 10% Owner |
2012-03-29 |
5,316,967 |
2011-10-21 |
229,567 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
Director, 10% Owner |
2013-03-20 |
3,412,793 |
2013-03-20 |
170,977 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2017-06-01 |
919 |
2017-06-01 |
377,782 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
1,114 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2013-12-13 |
5,000 |
2013-12-13 |
178,406 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
Yext Inc |
YEXT |
10% Owner |
|
0 |
2017-12-01 |
724,841 |
Premium* |
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2017-10-16 |
182,594 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MTEM |
Molecular Templates, Inc. |
10% Owner |
|
2008-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,626,575 |
|
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2009-10-05 |
4 |
B |
$1.91 |
$2,184,532 |
D/D |
1,143,734 |
3,678,983 |
3.92 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2009-10-05 |
4 |
B |
$1.91 |
$66,271 |
I/I |
34,697 |
111,116 |
2.25 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2011-03-11 |
4 |
B |
$2.10 |
$44,020 |
I/I |
20,962 |
132,078 |
2.25 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2011-12-09 |
4 |
A |
$0.00 |
$0 |
I/I |
75,944 |
208,022 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2011-12-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(386,307) |
3,983,645 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-05-31 |
4 |
S |
$5.72 |
$1,563,688 |
I/I |
(273,181) |
234,180 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-05-31 |
4 |
OE |
$1.86 |
$1,563,700 |
I/I |
840,699 |
246,769 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-06-20 |
4 |
S |
$4.01 |
$40,193 |
D/D |
(10,028) |
0 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-06-20 |
4 |
S |
$4.01 |
$15,872 |
D/D |
(3,960) |
0 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-06-20 |
4 |
S |
$4.01 |
$56,065 |
I/I |
(13,988) |
0 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-10-01 |
4 |
OE |
$2.05 |
$899,702 |
I/I |
438,879 |
256,009 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-10-01 |
4 |
S |
$3.77 |
$899,697 |
I/I |
(238,520) |
244,146 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2016-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
96,010 |
340,156 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2016-03-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(617,132) |
4,098,266 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(630,770) |
3,467,496 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2017-06-01 |
4 |
B |
$0.57 |
$289,773 |
I/I |
510,703 |
377,782 |
2.1 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,176,025 |
36,599 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2015-01-01 |
5/A |
D |
$0.00 |
$0 |
I/I |
(0) |
36,602 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2015-12-04 |
4 |
A |
$0.00 |
$0 |
I/I |
22,454 |
59,053 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2015-12-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(144,333) |
958,491 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2016-01-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
36,602 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2016-10-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
0 |
36,602 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2017-05-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(147,523) |
810,968 |
0 |
- |
|
143 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|